Which are the causes of Anal Cancer?

Anal cancer is primarily caused by persistent infection with high-risk human papillomavirus (HPV), which leads to cellular changes in the anal canal lining. While not directly hereditary, certain environmental and immune-related risk factors significantly increase the likelihood of developing anal cancer over time.

What causes anal cancer?

The development of anal cancer is a complex biological process where the genetic material of healthy anal cells is damaged, causing them to grow uncontrollably. The most significant cause is the human papillomavirus (HPV), specifically high-risk strains like HPV-16. When the body fails to clear an HPV infection, the virus integrates its DNA into the host cells, potentially triggering malignant transformation. It is important to distinguish between "causes" (the direct biological driver) and "risk factors" (conditions that increase vulnerability to those drivers).

Are there specific risk factors for anal cancer?

While HPV is the primary driver, several factors influence whether an infection progresses to anal cancer:

• Immunosuppression: Individuals with HIV or those taking immunosuppressive medications have a higher risk because the immune system cannot effectively clear the HPV virus.


• Smoking: Chemicals in tobacco can interfere with the body’s ability to repair DNA damage in anal cells.


• Chronic Inflammation: Conditions that cause long-term irritation in the anal area may contribute to cellular instability.


• Sexual History: Factors such as a high number of sexual partners or receptive anal intercourse increase the probability of HPV exposure.

Is anal cancer hereditary?

Anal cancer itself is not considered a hereditary disease, meaning it is not passed down through genes in the way that conditions like cystic fibrosis are. However, researchers are studying how individual variations in immune response genes might make some people more susceptible to persistent HPV infections, which in turn influences the development of anal cancer.

How is research evolving?

Current clinical research is focused on the "Anorectal Cancer Screening" (ANCHOR) study, which investigates whether treating precancerous anal lesions can effectively prevent anal cancer. Scientists are also looking at how the anal microbiome and specific immune biomarkers can predict which patients are at the highest risk for disease progression.

Next steps

• Consult a gastroenterologist or colorectal surgeon if you notice symptoms like bleeding, pain, or a lump in the anal area.


• Discuss HPV vaccination with your healthcare provider, as it is a primary prevention tool.


• Connect with the 8 members currently sharing their experiences with anal cancer on DiseaseMaps.org to find support and community resources.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• National Cancer Institute (NCI) - Anal Cancer Prevention and Risk Factors


• NIH Genetic and Rare Diseases (GARD) Information Center


• Centers for Disease Control and Prevention (CDC) - HPV and Cancer


• American Cancer Society - What Causes Anal Cancer?